文献速递间质性肺疾病

冷诱导RNA结合蛋白在特发性肺纤维化中的临床意义

Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
PubMed 文献 · Chest · 2021-07-09

本研究纳入两家独立医院的95例和93例IPF患者(衍生队列和验证队列),回顾性分析血清CIRBP水平与诊断后1年内疾病进展(FVC占预计值相对下降≥10%或死亡)及全因死亡的关联。结果显示高血清CIRBP独立预测1年疾病进展和全因死亡,联合GAP模型可提高预测c-index,尤其在GAP I期患者中CIRBP的c-index较高。

要点

  • 血清CIRBP水平在IPF患者中高于对照,高CIRBP组1年疾病进展率和死亡率更高。
  • 血清CIRBP是IPF患者1年疾病进展和全因死亡的独立预测因子。
  • CIRBP联合GAP模型可提高预测效能,尤其在GAP I期患者中CIRBP的c-index较高。

核心结论

  • 血清CIRBP水平是IPF患者1年疾病进展和全因死亡的独立预测因子,尤其有助于识别早期高风险患者。

研究设计与样本

  • 回顾性研究,纳入两家独立医院的95例(衍生队列)和93例(验证队列)IPF患者,分析血清CIRBP水平与诊断后1年内疾病进展及全因死亡的关联,并用c-index评估预测区分度。

主要发现

  • IPF患者血清和肺组织CIRBP水平高于对照。
  • 在衍生队列中,CIRBP高亚组的1年疾病进展率显著更高、累积生存率更低,并在验证队列中重复。
  • 多因素分析显示高血清CIRBP水平在两个队列中均与更高的1年疾病进展率和全因死亡率独立相关。
  • 联合GAP和血清CIRBP模型较各自单独模型提高了预测1年疾病进展和全因死亡的c-index。
  • 血清CIRBP的c-index在GAP I期患者中尤其高。

临床怎么用

  • 血清CIRBP可作为IPF预后评估的生物标志物,联合GAP模型有助于识别1年内疾病进展和死亡高风险患者,尤其在早期阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is associated with a poor prognosis with variable clinical course. Early identification of patients at high risk for disease progression and death would lead to early therapeutic intervention and thereby improvement of outcomes. Cold-inducible RNA-binding protein (CIRBP) is produced in response to cellular stresses, which is implicated in multiple biological processes, including cell survival and proliferation. RESEARCH QUESTION: Is CIRBP a useful biomarker for predicting the outcomes of patients with IPF? STUDY DESIGN AND METHODS: This study included 95 and 93 patients with IPF from two independent hospitals (derivation and validation cohorts, respectively). The associations of serum CIRBP level on IPF diagnosis with disease progression within 1 year after diagnosis (ie, ≥10% relative decline in percent predicted FVC or death) and all-cause mortality were retrospectively analyzed. Discrimination performances for predicting these outcomes were evaluated using the c-index. RESULTS: Serum and lung tissue CIRBP levels were higher in patients with IPF than in control subjects. In the derivation cohort, the CIRBPhigh subgroup had significantly higher 1-year disease progression rates and lower cumulative survival rates than the CIRBPlow subgroup, and the results were replicated in the validation cohort. In multivariate analyses, high serum CIRBP level was independently associated with higher 1-year disease progression and all-cause mortality rates in both cohorts. Combining the Gender-Age-Physiology (GAP) and serum CIRBP models improved the c-indexes for predicting 1-year disease progression and all-cause mortality compared with that of each model alone. The c-indexes of serum CIRBP were particularly high in patients with GAP stage I. INTERPRETATION: This study successfully validated that serum CIRBP level was an independent predictor of 1-year disease progression and all-cause mortality in IPF. CIRBP is a promising biomarker that can help identify high-risk patients with IPF, especially in the early stage.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Hozumi H, Kataoka K, Kondoh Y, et al. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis. Chest. 2021. PMID: 34252438. doi:10.1016/j.chest.2021.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。